The Role of IVERMECTIN in the Monumental decline of COVID19 Cases in INDIA

 

This was my June 2021 Article on Ivermectin use in India. I will make a follow-up article later which will really astonish everyone on Ivermectins Role in India. 

Ivermectin has been in the news since last year as it was and is used for the prevention, treatment, and management of COVID19 patients. Though the indication is, anti-parasitic, it has proven through several studies that it has both antiviral and anti-inflammatory properties. This has been prescribed and more than 3.5 billion pills have been taken orally since 1992, it has barely 19 deaths and 5, 236 adverse effects. It is also a Nobel prize awardee in the ranks of Aspirin and Penicillin.

   28% of the world's countries are currently using Ivermectin, however, out of the 32 countries only 13 are using it Countrywide. There are several randomized control trials for IVM which showed promising results. However, the Metanalysis presented by the Evidence-Based Consulting Group of Dr. Tess Lawrie provided all the rock-solid evidence needed to show the efficacy and safety of Ivermectin against COVID19

India has a mixed usage of Ivermectin in Different Regions. It is the second-most popul populous country in the world and has the second largest by land area.
India last month has been on the headlines, high spike of cases and shortages of oxygen supplies in the hospital. Let us look at the numbers and see where India was last month and where it is now at present in terms of the COVID19 crisis management.

On February 18, 2021 , an article entitled, "Role of Ivermectin in the Prevention of SARS Cov-2 Infection among healthcare workers in India: A matched case-control study," was published at PMC, US National Library of Medicine, National Institute of Health, The Conclusion was;

"Two-dose ivermectin prophylaxis at a dose of 300 μg/kg with a gap of 72 hours was associated with a 73% reduction of SARS-CoV-2 infection among healthcare workers for the following month. Chemoprophylaxis has relevance in the containment of pandemic."

On May 19, 2021, the AIIMS or All India Institute of Medicine and Sciences/ICMR- COVID19 National Task Force/Joint Monitoring Group included Ivermectin in the Treatment protocol for Mild Cases, a Clinical Guidance for Management of Adult Covid-19 patients.

Let us look at several regions that implemented the use of Ivermectin for mild COvid19 cases. The 4 Regions that we will look into are as follows; Delhi, Goa, Uttar Pradesh, and Tamil Nadu.

Delhi, India Capital has 18.98 million having a massive metropolitan area. Ivermectin was given to adults for mild symptoms.

Delhi showed a significant drop of COVID 19 cases From the peak of 24,331 last August 23, 2021, After starting the AIIMS protocol on May 19, on May 30, 2021, there were only 946 cases or a 96.11% decline of cases. The Death cases dropped by 80.8 %

Goa, the western state of India, made up of coastal lines has a population of 1.817 million (stats since 2012).

On May 10 a preemptive policy was adopted by giving Ivermectin to adults. There was a consistent downtrend within the month a 71.09% decrease of cases and a 70.6% decrease in deaths.

Uttar Pradesh Region, with more than 200 million inhabitants, is the most populous state of India.

On April 10, 2021 Ivermectin was introduced in accordance with the AIIMS COVID19 Guidelines.

“We introduced it (Ivermectin) for three days, 12 mg as advised in the national guidelines at the time, followed by tests on the fourth or fifth day." - Prabhu N Singh, Agra District Magistrate

From 37,944 last April 20, 2021, it had a sharp downtrend to 1,864 cases on June 2,2021, a 95.08% decrease. Deaths dropped 46.31 % as well.

The last Region is Tamil Nadu, located in the southern region with a population size of 67.86 million. This Region had a different approach in the management of COVID19." May 15, Madhu Pai, MD, Ph.D., professor of epidemiology & global health and the Christian Medical College Vellore in the southern state of Tamil Nadu group updated their guidance to state that it recommends "against using ivermectin for treatment of patients with any severity of COVID-19. Ivermectin should only be used in the context of a randomized controlled trial."

A decline of only 21.26% was noted in COVID19 cases after May 15 but still an uphill number of deaths. Same country, different management, different outcome.

In Summary;
1. Regions that used Ivermectin showed the ff:
a. 87.42 % average significant decrease of COVID19 cases
b. 65.9 % average decrease of COVID19 deaths
2. Region who banned Ivermectin:
a. 21.26% decrease of COVID19 cases
b. Death cases are still peaking

IVERMECTIN has a great role in the management of COVID19 infection. Despite that it was only given in mild cases and not in moderate to severe, Ivermectin has shown its efficacy. It would be good to take note that India has 11.2 percent of the population vaccinated on the first dose and 3.2% full vaccination. The vaccination cannot take credit for the dramatic decrease of cases and deaths. for a community to have herd Immunity, it has to have 70% to 90% vaccinated. Hence herd immunity is far from the truth in relation to the numbers seen at present.

It would be good to see the numbers and figures once IVM is used for moderate to severe COVID19 cases.

Reference:
https://ivmmeta.com/
https://ourworldindata.org/
http://bit.ly/COVID19SEARCH
https://www.mohfw.gov.in/pdf/COVID19ClinicalManagementProtocolAlgorithmAdults19thMay2021.pdf
https://www.medpagetoday.com/special-reports/exclusives/92644
https://indianexpress.com/article/cities/lucknow/uttar-pradesh-government-says-ivermectin-helped-to-keep-deaths-low-7311786

Message to your leaders if you had the opportunity to speak about Ivermectin for COVID19?

 

What will you say to your leaders if you had the opportunity to speak with them about Ivermectin.

By the way if your local leader, mayor, prime minster or any legislator are interested to know more about ivermectin, protocols etc. Email me at vvicente@althash.org We will be doing some fund raising in the near future to support Speaking for Truth and Love. On this video let us listen to the ff doctors. Dr. Pierre Kory - President of the Front-Line Covid-19 Critical Care Alliance Intensivist, Advocate Aurora Critical Care service Critical Care Service Chief – University of Wisconsin- Madison https://www.linkedin.com/in/pierre-ko... Dr. Mark Wathelet Consultant, coronavirus specialist – Belgium Scientist Lovelace Respiratory Research Insititute molecular and cellular biology, signal transduction and gene regulation, innate and adaptive immune responses, inflammatory response, antiviral response, cytokine storm, fibrosis, virology (BSL2,BSL3), viral vectors for gene expression (retroviruses, lentiviruses, adenoviruses, adeno-associated viruses, vaccinia virus, baculovirus), reversible cell immortalization, TALEN-based and CRISPR/Cas9 genome editing for functional genomics, live cell imaging and lung diseases. https://www.linkedin.com/in/marc-wath... Dr. Hector Carvallo Profesor Medicina, Universidad de Morón Profesor de Medicina UAI Ex Profesor Adjunto Medicina UBA • Máximo Paz, Buenos Aires Province, Argentina https://www.linkedin.com/in/h%C3%A9ct... Dr. Eli Schwartz Israel Chair Department of Tropical Med Moderator: Dr. Mobeen Syed visit FLCCC website: https://covid19criticalcare.com/​ Dr. Tess Lawrie A clinical doctor specializing in Ob-Gynecology, a research physician. She is The Director for Evidence Based Medicine Consultancy Ltd. Or EMBMC She is committed to improving the quality of healthcare through rigorous researches. Dr. Lawrie is a frequent member of technical teams responsible for developing international guidelines, her peer-reviewed publications, have received thousands of citations and her research gate score is among the top five percent of Research Gate member Data Matters/Evidence Matters we have the Randmozed Controlled Trial Results, we have a Meta analysis and we discussed this in this video. IVM Clinical Trials https://www.clinicaltrials.gov/ct2/re... Meta Analysis: https://journals.lww.com/americanther... Disclaimer: This is for education and awareness purposes, talk to your doctor if you need medical advice

Emerging Problems, DELTA Variant and COVAX Syndrome - a Doctors Experience

 

About our Guest: Dr. Marivic Villa Founder and Medical Director at Villa Health Center She is an Internal Medicine Pulmonary Critical Care Specialist Practicing in The Villages Florida The B.1.617.2 (delta) variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has contributed to a surge in cases in India and has now been detected across the globe, including a notable increase in cases in the United Kingdom What is so special about the Delta variant? About twice as transmissible as the original virus that emerged in late 2019, delta combines a multitude of genetic features that have enabled it to pierce public-health defenses to stoke severe epidemics and trigger fresh rounds of movement restrictions or delay planned easings of them ✅ My ODYSEE CHANNEL: https://odysee.com/@DocVince:c 🙏John 8:31-32 The Truth Will Set You Free 31 So Jesus said to the Jews who had believed him, “If you abide in my word, you are truly my disciples, 32 and you will know the truth, and the truth will set you free.” ✅ visit the WID site: https://worldivermectinday.org/ ✅ I LOVE IVM MuGS https://bit.ly/IVMMUGS ✅ Boost your Immune System with Intra Products: https://bit.ly/INTRDOC ✅ Open your first cryptocurrency account with Coinbase: You will receive $10 in free Bitcoin when you buy or sell your first $100 on Coinbase! https://www.coinbase.com/join/vicent_op ✅ open your CHASE BANK account: https://bit.ly/CHASEFRDM PROFESSIONAL DISCLAIMER: The Channel cannot and does not contain medical advice. The [medical/health/other information is provided for general informational and educational purposes only and is not a substitute for personal professional advice. However, most in the panel are subject matter experts, physicians, and specialists in their own respective fields. Accordingly, before taking any actions based upon such information, we encourage you to consult with the appropriate professionals. We do not provide any kind of medical advice. The use or reliance of any information contained on this site is solely at your own risk.